Vertebral Augmentation Patents: Who Leads, Where Gaps Are 2026
Vertebral Augmentation Patents: Concentration at the Top, Room at the Edges
26.9% held by five. The top five assignees combined account for 609 of the 2,262 records in scope, or 26.9% — a concentrated core rather than a fragmented field. Filings peaked at 69 in 2017. The most recent complete comparison — 2021's 50 filings against 2024's 37 — shows a 26% decline over three years; 2025 and 2026 are omitted from that read because publication lag of roughly 18 months means recent-year counts are still incomplete.
- 1DFINE INC7.9%
- 2DEPUY SYNTHES PROD INC5.2%
- 3ILLUMINOSS MEDICAL INC5.0%
- 4KYPHON SARL4.5%
- 5DEPUY SPINE INC4.3%
See the full vertebral augmentation analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on vertebral augmentation patents
Who holds the most patents in vertebral augmentation?
The dataset’s ranked leader holds 179 of the 2,262 records in scope, noticeably ahead of the fifth-ranked assignee at 97 and the tenth-ranked at 50. The top five assignees combined account for 26.9% of all records, and the top ten reach 42.2%. This points to a field with a clear leader and a broader competitive tier below it, rather than even fragmentation across many small filers.
Is vertebral augmentation patent filing growing or slowing?
Filing activity peaked in 2017 at 69 records and has eased since; comparing 2021 (50 filings) to 2024 (37 filings), the last year treatable as complete, shows a 26% decline. Because patent publication typically lags filing by around 18 months, the 2025 and 2026 figures in any dataset will understate true recent activity and should not be read as confirming a continued drop. A fair read is that the field has cooled from its 2017 peak but current-year trajectory is not yet visible.
What technology areas dominate vertebral augmentation patents?
Surgical procedure and delivery-device claims, classified under IPC A61B, appear in 68.2% of the 2,262 records in scope, making it the densest single class. Implant and prosthesis claims (A61F) follow at 35.5%, with sterilisation methods (A61L) at 25.1%. Cement formulation-adjacent classes such as A61C (dentistry, 2.1%) and A61P (therapeutic activity, 3.1%) are comparatively thin, suggesting procedural mechanics are more heavily claimed than material chemistry.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Vertebral Augmentation covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.